Monitoring Cognition in Patients Undergoing Anti‐Amyloid Therapies with A Remote App‐Based Digital Cognitive Assessment Tool

Abstract

Background: Mobile, valid and engaging cognitive assessments are essential for detecting and tracking change in cognition. With the approval of anti‐amyloid therapies (AATs), there is a need to monitor for both benefits and risks of these therapies.